Proteome Sciences plc
Market Cap
$4.10M
P/E Ratio
-1.56
EPS
$-0.01
Dividend Yield
0.00%
52-Week Range
$1.30 — $4.50
Volume
460.54K
Avg Volume
432.42K
Beta
0.20
P/E (TTM)
-1.56
Forward P/E
—
PEG Ratio
-0.57
P/S (TTM)
1.09
P/B (TTM)
-0.58
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
0.44%
ROA (TTM)
-0.40%
ROIC
—
Gross Margin
-0.01%
Operating Margin
-0.50%
Net Margin
—
Debt/Equity
-1.79
Current Ratio
0.11
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
+6.09%
EPS Growth (5Y)
+3.69%
Sales Growth (3Y)
-0.33%
Sales Growth (5Y)
-0.16%
EPS Est (This Year)
$-0.01
EPS Est (Next Year)
$-0.01
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$0.00
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
295.18M
Float
255.05M
Free Float %
86.41%
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Country
GB
Exchange
LSE
IPO Date
1995-10-03
Employees
36
CEO
Christopher Donovan James Pearce
Index Membership
—
Website
https://www.proteomics.com
Proteome Sciences plc (PRM.L) is a healthcare company in the medical - diagnostics & research industry listed on the LSE. With a market capitalization of $4.10M, a P/E ratio of -1.56, PRM.L is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare PRM.L against other stocks using dozens of fundamental and technical filters.
Proteome Sciences plc (PRM.L) has a trailing twelve-month (TTM) P/E ratio of -1.56. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Proteome Sciences plc (PRM.L) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Proteome Sciences plc (PRM.L) has a market capitalization of $4.10 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.